Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MLYS

Mineralys Therapeutics Inc

May 29 • 04:00PM ET

31.50

-0.04 -0.13 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: CGON KYMR NUVL INCY RYTM APGE KRYS AXSM BMRN NBIX

| Held by: XBI VTI IWM VXF IBB IWO SCHA VTWO IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.06	Insider Own	26.48%	Shs Outstand	82.45M	Perf Week	4.20%
Market Cap	2.60B	Forward P/E	-	EPS next Y	-2.08	Insider Trans	-0.61%	Shs Float	60.66M	Perf Month	23.24%
Enterprise Value	1.95B	PEG	-	EPS next Q	-0.55	Inst Own	88.35%	Short Float	14.88%	Perf Quarter	7.66%
Income	-151.78M	P/S	-	EPS this Y	-1.25%	Inst Trans	1.67%	Short Ratio	7.11	Perf Half Y	-25.36%
Sales	0.00M	P/B	4.07	EPS next Y	10.34%	ROA	-30.12%	Short Interest	9.02M	Perf YTD	-13.20%
Book/sh	7.74	P/C	4.02	EPS next 5Y	19.83%	ROE	-30.98%	52W High	47.65 -33.89%	Perf Year	101.15%
Cash/sh	7.83	P/FCF	-	EPS past 3/5Y	-46.34% -101.68%	ROIC	-23.78%	52W Low	12.59 150.20%	Perf 3Y	123.72%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.33% 5.71%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	44.87%	Oper. Margin	-	ATR (14)	1.63	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	44.33	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	63.07	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	44.33	EPS Q/Q	40.19%	SMA20	8.31%	Beta	0.56	Target Price	48.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	13.76%	Rel Volume	0.86	Prev Close	31.54
Employees	76	LT Debt/Eq	0.00	Earnings	May 06 AMC	SMA200	-2.94%	Avg Volume	1.27M	Price	31.50
IPO	Feb 10, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.47% -	Trades		Volume	1,090,922	Change	-0.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)